AXOVIA THERAPEUTICS LTD

14715294
Active London

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

AXOVIA THERAPEUTICS LTD

14715294

Research and experimental development on biotechnology

Founded 8 Mar 2023 Active London, England 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 23 Apr 2026 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 9 Mar 2026 Next due 21 Mar 2027 8 months remaining
Net assets £3M £3M 2025 year on year
Total assets £4M £2M 2025 year on year
Total Liabilities £527K £5M 2025 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

78 Pall Mall London SW1Y 5ES England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for AXOVIA THERAPEUTICS LTD (14715294), an active life sciences and medical technology company based in London, England. Incorporated 8 Mar 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type micro-entity
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Net Assets, Total Assets & Total Liabilities (2023–2025)

Cash in Bank

£2.68M

Net Assets

£3.22M

Increased by £2.95M (+1087%)

Total Liabilities

£527.21k

Decreased by £4.88M (-90%)

Turnover

N/A

Employees

8

Debt Ratio

14%

Decreased by 81 (-85%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 196,976 Shares £6896.41m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Oct 2025130,487£5.79m£44.35
21 Oct 202540,239£40.239£0.001
16 Oct 202326,250£6890.63m£263k

Officers

Officers

3 active
Status
Balfour, Robert Henry, DrDirectorBritishEngland4624 May 2023Active
Goldsmith, Bruce AokiDirectorAmericanUnited States603 Feb 2025Active
Safarian, AlekDirectorAustralianUnited States618 Mar 2023Active

Shareholders

Shareholders (7)

Alsa Ventures I Scsp
42.4%
183,750
Alsa Ventures I Scsp
29.0%
125,440

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Mr Alek Safarian

Australian

Active
Notified 8 Mar 2023
Residence United States
DOB October 1964
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent
  • Right To Appoint And Remove Directors

Alsa Ventures I Scsp

Luxembourg

Active
Notified 12 May 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

AXOVIA THERAPEUTICS LTD Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
9 Mar 2026Confirmation StatementConfirmation statement made on 7 Mar 2026 with updates
6 Mar 2026MortgageMortgage Satisfy Charge Full
6 Mar 2026MortgageMortgage Satisfy Charge Full
1 Dec 2025ResolutionResolutions
23 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

9 Mar 2026 Confirmation Statement

Confirmation statement made on 7 Mar 2026 with updates

6 Mar 2026 Mortgage

Mortgage Satisfy Charge Full

6 Mar 2026 Mortgage

Mortgage Satisfy Charge Full

1 Dec 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 months ago on 23 Apr 2026

Confirmation statement made on 7 Mar 2026 with updates

4 months ago on 9 Mar 2026

Mortgage Satisfy Charge Full

4 months ago on 6 Mar 2026

Mortgage Satisfy Charge Full

4 months ago on 6 Mar 2026

Resolutions

7 months ago on 1 Dec 2025